Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma.

ABSTRACT:

SUBMITTER: Flinsenberg TWH 

PROVIDER: S-EPMC7012496 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature